APA (7th ed.) Citation

Mase, S., Chorba, T., Parks, S., Belanger, A., Dworkin, F., Seaworth, B., . . . Shah, N. (2020). Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States. Clinical infectious diseases, 71(4), 1010. https://doi.org/10.1093/cid/ciz914

Chicago Style (17th ed.) Citation

Mase, Sundari, Terence Chorba, Samuel Parks, Ann Belanger, Felicia Dworkin, Barbara Seaworth, Jon Warkentin, Pennan Barry, and Neha Shah. "Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States." Clinical Infectious Diseases 71, no. 4 (2020): 1010. https://doi.org/10.1093/cid/ciz914.

MLA (9th ed.) Citation

Mase, Sundari, et al. "Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States." Clinical Infectious Diseases, vol. 71, no. 4, 2020, p. 1010, https://doi.org/10.1093/cid/ciz914.